[The use of plasmapheresis in treating urology patients].
The paper presents the results of plasmapheresis inclusion into a combined therapy of pyelonephritis. Out of 79 patients treated, 42 had urosepsis, 25 developed pyelonephritis in pregnancy, 12 had complicating chronic renal failure. Uroseptic patients were examined for hemostasis, the rest for immune status. There were symptoms of DIC syndrome in the former and immunity suppression in the latter. After the combined therapy with plasmapheresis, latent hypercoagulation and intoxication disappeared, uroseptic manifestations reduced. The above treatment of pregnancy pyelonephritis stopped inflammation, promoted activation of the immune system. In patients with chronic renal failure adjuvant plasmapheresis enhanced cellular and humoral immunity, neutrophil function, the number of middle-size molecules in the blood diminished. The latter improved renal function in decreasing uremia.
Neĭmark
A I
AI
Astakhov
Iu I
IuI
Davydov
A V
AV
Mazyrko
A V
AV
Iakovets
Ia V
IaV
D000293:Adolescent; D000328:Adult; D005260:Female; D006487:Hemostasis; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000276:immunology / Q000628:therapy; D008875:Middle Aged; D010956:Plasmapheresis; D011183:Postoperative Complications / Q000097:blood / Q000276:immunology / Q000628:therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood / Q000276:immunology / Q000628:therapy; D011704:Pyelonephritis / Q000097:blood / Q000276:immunology / Q000628:therapy; D014118:Toxins, Biological / Q000097:blood; D014511:Uremia / Q000097:blood / Q000276:immunology / Q000628:therapy; D014552:Urinary Tract Infections / Q000097:blood / Q000276:immunology / Q000628:therapy; D014570:Urologic Diseases / Q000097:blood / Q000276:immunology / Q000628:therapy*
D014118:Toxins, Biological; C026865:uremia middle molecule toxins
Ispol'zovanie plazmafereza v lechenii urologicheskikh bol'nykh.